FT
Fate Therapeutics Inc
🇺🇸XNAS.FATEUnited StatesHealthcare
$2.32USDdown -0.02 (-0.85%)OpenEnd of day2:26 PM
Price$2.32-0.02 (-0.85%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US31189P1021
- CUSIP
- 31189P102
Company
- Employees
- 161
- Headquarters
- San Diego, United States
- CEO
- Dr. Bahram Valamehr M.B.A., Ph.D.
Market
- Shares outstanding
- 119.8M
- Market cap
- $277.98M
Highlights
- Market cap
- $277.98M
- EPS LTM
- -$1.05
- P/E LTM
- -2.58
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $6.49M-23.36%down year on year
- Net income
- -$126M+26.54%up year on year
- Gross margin
- -390.2%+56.67%up year on year
- Free cash flow
- -$105.66M+11.04%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.